INS and type 2 diabetes mellitus: Tissue specific TXNIP deletion in adipose or skeletal muscle exhibited powerful insulin sensitization with no evidence of tumorigenesis, therefore AAV-CRISPR mediated TXNIP deletion in those tissues would be beneficial for treating T2D.